Reinduction Chemotherapy with Gemtuzumab Ozogamicin and Intermediate/High-Dose Cytarabine: A Single-Center Experience

Journals Menu

Follow SCIRP

ISSN Print: 2164-3180
ISSN Online: 2164-3199
www.scirp.org/journal/ojbd
E-mail: ojbd@scirp.org

"Reinduction Chemotherapy with Gemtuzumab Ozogamicin and Intermediate/High-Dose Cytarabine: A Single-Center Experience"
written by Sohsuke Meshitsuka, Mitsuo Hori, Shoichi Mitsuhashi, Yasushi Okoshi, Hiroshi Kojima,
published by Open Journal of Blood Diseases, Vol.4 No.1, 2014

has been cited by the following article(s):

[1]	Enasidenib: first mutant IDH2 inhibitor for the treatment of refractory and relapsed acute myeloid leukemia
	2018

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top